Detalles de la búsqueda
1.
Plasma xanthine oxidoreductase is associated with carotid atherosclerosis in stable kidney transplant recipients.
Nephrology (Carlton);
27(4): 363-370, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34626042
2.
Associations of circulating xanthine oxidoreductase activity with cardiometabolic risk markers in overweight and obese Japanese men: a cross-sectional pilot study.
J Clin Biochem Nutr;
71(2): 122-128, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36213790
3.
Systemic Endothelial Function, Plasma Xanthine Oxidoreductase Activity, and Blood Pressure Variability in Patients with Stable Coronary Artery Disease.
Medicina (Kaunas);
58(10)2022 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36295583
4.
Greater coronary lipid core plaque assessed by near-infrared spectroscopy intravascular ultrasound in patients with elevated xanthine oxidoreductase: a mechanistic insight.
Heart Vessels;
36(5): 597-604, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33219412
5.
Seasonal variations for newly prescribed urate-lowering drugs for asymptomatic hyperuricemia and gout in Japan.
Front Pharmacol;
15: 1230562, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38292940
6.
The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study.
Biomedicines;
11(3)2023 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36979653
7.
Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry.
Int J Cardiol Heart Vasc;
48: 101264, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37680549
8.
The reality of treatment for hyperuricemia and gout in Japan: A historical cohort study using health insurance claims data.
J Clin Hypertens (Greenwich);
24(8): 1068-1075, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35818841
9.
Xanthine oxidoreductase activity in marathon runners: potential implications for marathon-induced acute kidney injury.
J Appl Physiol (1985);
133(1): 1-10, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35608201
10.
Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees.
Sci Rep;
12(1): 10281, 2022 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717455
11.
Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice.
Nutr Diabetes;
11(1): 12, 2021 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33850106
12.
Association between plasma xanthine oxidoreductase activity and in-hospital outcomes in patients with stable coronary artery disease after percutaneous coronary intervention.
PLoS One;
16(9): e0257227, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34520495
13.
Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation.
JCI Insight;
6(17)2021 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34494551
14.
Independent association of plasma xanthine oxidoreductase activity with hypertension in nondiabetic subjects not using medication.
Hypertens Res;
44(9): 1213-1220, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34117403
15.
Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry.
Sci Rep;
11(1): 7378, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33795813
16.
Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment.
J Diabetes Investig;
12(8): 1512-1520, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33211396
Resultados
1 -
16
de 16
1
Próxima >
>>